BTIG Reiterates Buy Rating on Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)

Market Context

Harrow Health, Inc. 11.875% Senior Notes due 2027 operates in the Healthcare sector. The stock currently trades at $26.03 with a market capitalization of $1.3B.

Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Harrow Health, Inc. 11.875% Senior Notes due 2027.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Harrow Health, Inc. 11.875% Senior Notes due 2027

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 21, 2026	BTIG	Buy	N/A
May 13, 2026	Cantor Fitzgerald	Overweight	N/A
May 12, 2026	BTIG	Buy	N/A
Apr 17, 2026	BTIG	Buy	N/A
Apr 07, 2026	B. Riley Securities	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View HROWM Stock Page